Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Observational

Evaluating the Clinical Suitability of Microsoft Xbox One Games in Geriatric Rehabilitation

NCT07562893 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2026-04-30
Last updated
2026-05-01

Condition(s) studied

GeriatricElderly (People Aged 65 or More)

Investigational drug(s) / intervention(s)

Exergame Applications Assessment

Exergame Applications Assessment: The 'Exergame Applications Assessment Form-Geriatrics (EUDF-G)', to be used in this research, is an assessment form developed by our research team to evaluate the clinical suitability of commercially available games. This form, not directly taken from any existing scale, is structured by combining internationally valid models such as technological usability (SUS), game experience (GEQ), enjoyment of physical activity (PACES-S), and exergame motivation (EEQ) with elderly population-specific motor-safety criteria (Gerling et al., 2012; Marston \& Smith, 2013). This hybrid structure constitutes the unique value of our study, offering a systematic assessment pool designed by our researchers for the clinical selection of Microsoft Xbox One games in the field of geriatric rehabilitation.

Study summary

This study aims to determine the potential for 'safe' and 'effective' use of Microsoft Xbox One-based motion games for the geriatric population through expert consensus using a unique set of assessments, and to provide clinicians with an evidence-based guide to game selection.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: 1. To be a Physiotherapist with at least 5 years of clinical/academic experience in geriatric rehabilitation or neurological rehabilitation, 2. To be a researcher in game technologies, Exergame applications, or Kinect systems, and to be a Physiotherapist with clinical/academic experience, 3. To approve the 'Informed Consent Form' regarding participation in the study. Exclusion Criteria: 1. Not having conducted research/academic activities in the specified areas of expertise (Physiotherapy, Gerontology, Play Technologies), 2. Failure to provide feedback within the specified timeframes, 3. Withdrawing voluntarily at any stage of the study.

Primary outcome measure(s)

  • Exergame Applications Evaluation Form-Geriatrics (EUDF-G): — 1 week
    The 'Exergame Applications Evaluation Form-Geriatrics (EUDF-G)', to be used in this research, is an evaluation form developed by our research team to assess the clinical suitability of commercially available games. This form, not directly derived from any existing scale, is structured by combining internationally valid models such as technological usability (SUS), game experience (GEQ), enjoyment of physical activity (PACES-S), and exergame motivation (EEQ) with elderly population-specific motor-safety criteria (Gerling et al., 2012; Marston \& Smith, 2013). This hybrid structure constitutes the unique value of our study, offering a systematic evaluation pool designed by our researchers for the clinical selection of Microsoft Xbox One games in the field of geriatric rehabilitation.

Trial sites (1)

FacilityCityRegionStatus
Balıkesir University Balıkesir Turkey (Türkiye)
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07562893 on ClinicalTrials.gov ↗ ← All trials in Turkey